Total Payments
$83,965
2024 Payments
$14,325
Companies
48
Transactions
329
Medicare Patients
1,649
Medicare Billing
$153,332
Payment Breakdown by Category
Other$40,273 (48.0%)
Travel$31,864 (37.9%)
Food & Beverage$8,476 (10.1%)
Research$2,489 (3.0%)
Education$861.61 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $38,775 | 21 | 46.2% |
| Travel and Lodging | $31,864 | 34 | 37.9% |
| Food and Beverage | $8,476 | 233 | 10.1% |
| Unspecified | $2,489 | 13 | 3.0% |
| Long term medical supply or device loan | $1,498 | 17 | 1.8% |
| Education | $861.61 | 11 | 1.0% |
Payments by Type
General
$81,476
316 transactions
Research
$2,489
13 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $64,836 | 75 | $0 (2024) |
| Genmab U.S., Inc. | $7,325 | 11 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $2,489 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,662 | 29 | $0 (2024) |
| ABBVIE INC. | $1,498 | 12 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $893.52 | 26 | $0 (2024) |
| Lilly USA, LLC | $821.27 | 24 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $599.57 | 12 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $580.18 | 28 | $0 (2024) |
| Amgen Inc. | $307.08 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14,325 | 126 | Genmab U.S., Inc. ($7,325) |
| 2023 | $17,336 | 81 | Genentech USA, Inc. ($15,391) |
| 2022 | $46,163 | 90 | Genentech USA, Inc. ($44,756) |
| 2021 | $6,141 | 32 | Genentech USA, Inc. ($4,667) |
All Payment Transactions
329 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $83.33 | General |
| Category: Oncology | ||||||
| 12/10/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: Oncology | ||||||
| 11/26/2024 | Genentech USA, Inc. | Tecentriq (Biological), Tecentriq Hybreza | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: BioOncology | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: Oncology | ||||||
| 11/18/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $34.97 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Travel and Lodging | Cash or cash equivalent | $83.36 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $83.33 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | Cash or cash equivalent | $52.24 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi, Nubeqa | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Oncology | ||||||
| 11/11/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $108.51 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Travel and Lodging | In-kind items and services | $1,197.24 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Travel and Lodging | In-kind items and services | $293.78 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: Oncology | ||||||
| 10/24/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2024 | Incyte Corporation | — | Education | Cash or cash equivalent | $74.99 | General |
| 10/21/2024 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: ONCOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) | Regeneron Pharmaceuticals, Inc. | $2,489 | 13 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 344 | 450 | $134,279 | $33,928 |
| 2022 | 2 | 350 | 440 | $130,424 | $34,775 |
| 2021 | 3 | 430 | 573 | $163,567 | $44,365 |
| 2020 | 2 | 525 | 655 | $199,580 | $40,263 |
Total Patients
1,649
Total Services
2,118
Medicare Billing
$153,332
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 222 | 314 | $102,872 | $26,284 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 122 | 136 | $31,407 | $7,644 | 24.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 225 | 300 | $97,927 | $27,070 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 125 | 140 | $32,497 | $7,705 | 23.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 247 | 349 | $114,368 | $33,263 | 29.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 168 | 189 | $47,822 | $10,834 | 22.7% |
| 93793 | Anti-clotting management for patient taking warfarin | Office | 2021 | 15 | 35 | $1,377 | $267.75 | 19.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 334 | 430 | $140,180 | $29,580 | 21.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 191 | 225 | $59,400 | $10,684 | 18.0% |
About Jonathan King, NP
Jonathan King, NP is a Family healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2018. The National Provider Identifier (NPI) number assigned to this provider is 1174023352.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jonathan King, NP has received a total of $83,965 in payments from pharmaceutical and medical device companies, with $14,325 received in 2024. These payments were reported across 329 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($38,775).
As a Medicare-enrolled provider, King has provided services to 1,649 Medicare beneficiaries, totaling 2,118 services with total Medicare billing of $153,332. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Tyler, TX
- Active Since 02/14/2018
- Last Updated 07/18/2019
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1174023352
Products in Payments
- TECENTRIQ (Biological) $40,872
- Epkinly (Drug) $7,325
- Tecentriq (Biological) $3,881
- EPKINLY (Drug) $1,492
- KISQALI (Drug) $1,279
- LIBTAYO (Biological) $580.18
- MYRISK (Device) $564.13
- myRisk (Device) $329.39
- IMFINZI (Biological) $231.16
- FOTIVDA (Drug) $170.58
- DARZALEX (Drug) $140.57
- Vonjo (Drug) $125.01
- NERLYNX (Drug) $125.00
- Orserdu (Drug) $117.52
- VERZENIO (Drug) $115.61
- XYWAV (Drug) $111.49
- ZEJULA (Drug) $90.79
- ZEPZELCA (Drug) $82.43
- Sylvant (Drug) $82.01
- ELITEK (Biological) $77.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Tyler
Kirsten Stuber, Fnp-Bc, FNP-BC
Family — Payments: $66,199
Family $66,199
Machelle Mcdowell, Fnp, Np-C, FNP, NP-C
Family — Payments: $63,178
Family $63,178
Amanda George, Aprn, Bc Fnp, APRN, BC FNP
Family — Payments: $8,588
Family $8,588
Brandi Dunford, Fnp-C, FNP-C
Family — Payments: $6,695
Family $6,695
Tiffiney Mcmakin, Np, NP
Family — Payments: $6,483
Family $6,483
Natalye Combs, Msn, Aprn, Fnp-C, MSN, APRN, FNP-C
Family — Payments: $6,338
Family $6,338